Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Clinical evidence evaluation of Xuebijing Injection in the treatment of viral pneumonia
Hits 14  Download times 1  Received:June 08, 2024  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2024.12.11
Key Words   viral pneumonia;Xuebijing Injection;combination of traditional Chinese and Western medicine;Meta-analysis;clinical evidence
Author NameAffiliationE-mail
DU Xuechen Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
PANG Wentai Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
SONG Geliang Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
WANG Chunyang Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
CAO Lujia Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
AN Jiali Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
ZHONG Mengyuan Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
ZHUANG Ming Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
JIN Xinyao Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China jxytcm@yeah.net 
ZHENG Wenke Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
Haihe Laboratory of Modern Traditional Chinese Medicine, Tianjin 301617, China 
zhengwk2020@tjutcm.edu.cn 
Abstract
    [Objective] To systematically evaluate the clinical evidence of Xuebijing Injection in the treatment of viral pneumonia. [Methods] We search the Chinese and English databases to collect the clinical studies of Xuebijing Injection in the treatment of viral pneumonia. The search time limit was from the establishment of the database to July,2024. We selected the appropriate quality evaluation to adapt the design type included in the study and used R software to analyze Meta. [Results] A total of 8 articles were included,and the overall study quality was not elevated. Meta-analysis results showed that the Xuebijing Injection group had advantages in the improvement rate of symptoms(fever,fatigue,shortness of breath),physical and chemical indicators(leukocyte count,lymphocyte count,C-reactive protein,interleukin-6,tumor necrosis factor),disease outcome(length of stay in ICU,use rate of mechanical ventilation,use rate of non-invasive mechanical ventilation,weight conversion rate in 14 days,incidence rate of ARDS,incidence rate of septic shock) and other effective indicators. The difference between groups was statistically significant(P<0.05). There was no significant difference in safety indexes between the two groups(P>0.05). [Conclusion] Xuebijing Injection is safe and effective in the treatment of viral pneumonia,but the research quality is low,which affects the reliability of the results.

You are the 2348060 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.